RA Capital Management® (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital® to provide seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization.At RA Capital’s core is its TechAtlas research division, a scientifically trained team that maps out competitive landscapes in a continual effort to put data into context, identify breakthroughs, and originate conviction in new ideas. TechAtlas provides RA Capital’s investment team and portfolio companies with strategic intelligence, market research, and other resources. The team’s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.

Vor Biopharma

Wave Life Sciences

Shockwave Medical

G1 Therapeutics

Global Blood Therapeutics

Graphite Bio

Imara

Solid Biosciences

Spero Therapeutics

Stoke Therapeutics

Vaxcyte

T2 Biosystems

Tenaya Therapeutics

Crinetics Pharmaceuticals

Cybin

Cyteir Therapeutics

Day One Biopharmaceuticals

Nimbus Therapeutics

Novavax

Pardes Biosciences

Point Biopharma

Janux Therapeutics

Kala Pharmaceuticals

KalVista Pharmaceuticals

Legend Biotech

Lyra Therapeutics

Moderna

Natera

Acrivon Therapeutics

Invivyd

Agile Therapeutics

Akouos

AN2 Therapeutics

Arcutis Biotherapeutics

Ardelyx

Ascendis Pharma

Third Harmonic Bio

Verve Therapeutics

Athersys

Dice Therapeutics

FORMA Therapeutics

Biohaven Pharmaceutical

Black Diamond Therapeutics

Bluebird Bio

Blueprint Medicines

Bolt Biotherapeutics

Bristol-Myers Squibb

Century Therapeutics

Cerevel Therapeutics

Nautilus Biotechnology

New Amsterdam Pharma

Coherus Biosciences

Sierra Oncology

EyePoint Pharmaceuticals

RA Capital Management

Cascadia Capital is a financial services firm offering capital allocation strategies and investment advisory services.

Cascadia Capital

Kohlberg & Company is a financial services firm specializing in capital allocation strategies and portfolio management solutions.

Kohlberg & Company

Brockett Tamny & Co. is a financial services firm that provides capital allocation strategies and investment advisory services.

Brockett Tamny & Co.

RACAP is a financial services firm specializing in capital allocation strategies and portfolio management solutions. The company leverages advanced analytics and market insights to optimize investment decisions for its clients.

RACAP

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 10, 2024 11:33 PM	425b4aad
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	7609dfe3
crunchbase profile	general
li profile	general	May 10, 2024 11:33 PM	040dd39e
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:RACAP

RACAP